Next Article in Journal
Analysis of Replication, Cell Division-Mediated Spread, and HBV Envelope Protein-Dependent Pseudotyping of Three Mammalian Delta-like Agents
Next Article in Special Issue
Hepatitis C (HCV) Reinfection and Risk Factors among Clients of a Low-Threshold Primary Healthcare Service for People Who Inject Drugs in Sydney, Australia
Previous Article in Journal
First Characterization of Acinetobacter baumannii-Specific Filamentous Phages
Previous Article in Special Issue
Evaluation of a Project Integrating Financial Incentives into a Hepatitis C Testing and Treatment Model of Care at a Sexual Health Service in Cairns, Australia, 2020–2021
 
 

Order Article Reprints

Journal: Viruses, 2024
Volume: 16
Number: 858

Article: Virologic Response and Reinfection Following HCV Treatment among Hospitalized People Who Inject Drugs: Follow-Up Data from the OPPORTUNI-C Trial
Authors: by Kristian Braathen Malme, Kathrine Stene-Johansen, Ingvild Klundby, Øystein Backe, Tarjei Foshaug, Maria Helseth Greve, Charlotte Meinich Pihl, Ane-Kristine Finbråten, Olav Dalgard and Håvard Midgard
Link: https://www.mdpi.com/1999-4915/16/6/858

MDPI provides article reprints in high quality with convenient shipping to destinations worldwide. The articles are printed in on premium paper with high-resolution figures. Our covers are customized to your article and designed to be complimentary to the journal. These reprints are ideal additions to your portfolio. Copy details: 135g/m2 paper, 2x stitched, full colour and glossy finish, orderable in quantities from 10 to 1000.

If you have any questions, or special requests, please write to our support team; we are happy to provide you with the information you need.

Reprint Options

If you need more than 400 copies, please contact us by e-mail (publisher@mdpi.com) and we will prepare an individual offer for you.

Order Cost and Details

Contact Person

Invoice Address

Notes or Comments

Validate and Place Order

The order must be prepaid after it is placed

req denotes required fields.
Back to TopTop